MRK
Merck & Company Inc
NYSE: MRK · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$109.18
-1.60% today
Updated 2026-04-29
Market cap
$274.03B
P/E ratio
15.24
P/S ratio
4.22x
EPS (TTM)
$7.28
Dividend yield
2.94%
52W range
$71 – $124
Volume
9.8M
Merck & Company Inc (MRK) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $44.57B | $48.35B | $47.20B | $112.31B | $105.78B | $105.13B | $106.13B | $105.64B | $98.17B | $101.68B | $95.38B | $87.87B | $82.64B | $84.40B | $91.59B | $105.69B | $109.16B | $106.67B | $117.11B | — |
| Cash & equivalents | $5.91B | $5.34B | $4.37B | $9.31B | $10.90B | $13.53B | $13.45B | $15.62B | $7.44B | $8.52B | $6.51B | $6.09B | $7.96B | $9.68B | $8.05B | $8.10B | $12.69B | $6.84B | $13.24B | $18.21B |
| Current assets | $15.23B | $15.05B | $19.11B | $28.43B | $29.06B | $33.18B | $34.86B | $35.69B | $32.60B | $29.75B | $30.61B | $24.77B | $25.88B | $27.48B | $27.76B | $30.27B | $35.72B | $32.17B | $38.78B | — |
| Total liabilities | $24.60B | $27.76B | $26.03B | $50.83B | $48.98B | $48.19B | $50.67B | $53.32B | $49.38B | $56.91B | $55.07B | $53.30B | $55.76B | $58.40B | $66.18B | $67.44B | $63.10B | $69.04B | $70.73B | $-51.91B |
| Current liabilities | $12.72B | $12.26B | $14.32B | $15.64B | $15.64B | $16.25B | $18.35B | $17.87B | $18.40B | $19.20B | $17.20B | $18.61B | $22.21B | $22.22B | $27.33B | $23.87B | $24.24B | $25.69B | $28.42B | — |
| Long-term debt | $5.55B | $3.92B | $3.94B | $16.07B | $15.48B | $15.53B | $16.25B | $20.54B | $18.70B | $23.93B | $24.27B | $21.35B | $19.81B | $22.74B | $25.36B | $30.69B | $28.75B | $33.68B | $34.46B | — |
| Shareholder equity | $17.56B | $18.18B | $18.76B | $59.06B | $54.38B | $54.52B | $53.02B | $49.77B | $48.65B | $44.68B | $40.09B | $34.34B | $26.70B | $25.91B | $25.32B | $38.18B | $45.99B | $37.58B | $46.31B | $51.91B |
| Retained earnings | $39.10B | $39.14B | $43.70B | $41.41B | $37.54B | $38.99B | $39.98B | $39.26B | $46.02B | $45.35B | $44.13B | $41.35B | $42.58B | $46.60B | $47.36B | $53.70B | $61.08B | $53.90B | $63.07B | — |
| Accounts receivable | $3.31B | $3.64B | $2.91B | $6.60B | $7.34B | $8.26B | $7.67B | $7.18B | $6.63B | $6.48B | $7.02B | $6.87B | $7.07B | $6.78B | $6.80B | $9.23B | $9.45B | $10.35B | $10.28B | — |
| Inventory | $1.77B | $1.88B | $2.09B | $8.05B | $5.87B | $6.25B | $6.54B | $6.23B | $5.57B | $4.70B | $4.87B | $5.10B | $5.44B | $5.98B | $5.55B | $5.95B | $5.91B | $6.36B | $6.11B | — |
| Goodwill | $1.43B | $1.45B | $1.44B | $12.04B | $12.38B | $12.15B | $12.13B | $12.30B | $12.99B | $17.72B | $18.16B | $18.28B | $18.25B | $19.43B | $18.88B | $21.26B | $21.20B | $21.20B | $21.67B | — |